NCT06529445View on ClinicalTrials.gov

Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 22, 2024

Primary Completion Date

August 26, 2024

Study Completion Date

August 26, 2024

Conditions
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Interventions
DRUG

High Dose VC004 Capsules

VC004 Capsules qd per period, for two periods

DRUG

Median Dose VC004 Capsules

VC004 Capsules qd per period, for two periods

DRUG

Low Dose VC004 Capsules

VC004 Capsules qd per period, for two periods

Trial Locations (1)

210009

Zhongda Hospital,Affiliated to Southeast University, Nanjing

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY

NCT06529445 - Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter